DIFFERENTIATION OF HUMAN LEUKEMIAS IN RESPONSE TO 12-0-TETRADECANOYLPHORBOL-13-ACETATE INVITRO

Authors:
  • LPL Pegoraro
    L Pegoraro
  • JAJ Abrahm
    J Abrahm
  • RCR A Cooper
    R A Cooper
  • ALA Levis
    A Levis
  • BLB Lange
    B Lange
  • PMP Meo
    P Meo
  • GRG Rovera
    G Rovera

  • 1 January 1980
    • journal article
    • research article
    • Vol. 55  (5) , 859-862
    • PMID:6928789
Abstract
Leukemic cells from patients with acute myeloid leukemia underwent morphological, functional and histochemical changes within 24-48 h after treatment with 1.6 .times. 10-18 M 12-O-tetradecanoylphorbol-13-acetate (TPA). The changes included adhesion to the plastic substrate, a 4- to 6-fold increase in the number of phagocytic cells and an increase in the number of .alpha.-naphthyl-acetate esterase (.alpha.-NAE) positive cells. TPA treatment of cells from patients with acute lymphoblastic leukemia caused some aggregation of cells in suspension, but no changes in adhesion, phagocytosis or .alpha.-NAE. Of the 4 cases of undifferentiated or unclassified leukemias studied, two failed to respond to TPA, one responded with a myeloid (adhesion) pattern, and one with a lymphoid (aggregation) pattern. Leukemic myeloblasts apparently retain the ability to express a variety of differentiated functions. It may be possible to use TPA as a tool to test the differentiative potential of undifferentiated human leukemias.